Cargando…

Carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa causing infection in Africa and the Middle East: a surveillance study from the ATLAS programme (2018–20)

OBJECTIVES: To determine the in vitro susceptibility of Enterobacterales (n = 5457) and Pseudomonas aeruginosa (n = 1949) isolated from hospitalized patients in Africa (three countries) and the Middle East (five countries) in 2018–20 to a panel of 11 antimicrobials and to identify β-lactamase/carbap...

Descripción completa

Detalles Bibliográficos
Autores principales: Karlowsky, James A, Bouchillon, Samuel K, El Mahdy Kotb, Ramy, Mohamed, Naglaa, Stone, Gregory G, Sahm, Daniel F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204471/
https://www.ncbi.nlm.nih.gov/pubmed/35733913
http://dx.doi.org/10.1093/jacamr/dlac060
_version_ 1784728934262243328
author Karlowsky, James A
Bouchillon, Samuel K
El Mahdy Kotb, Ramy
Mohamed, Naglaa
Stone, Gregory G
Sahm, Daniel F
author_facet Karlowsky, James A
Bouchillon, Samuel K
El Mahdy Kotb, Ramy
Mohamed, Naglaa
Stone, Gregory G
Sahm, Daniel F
author_sort Karlowsky, James A
collection PubMed
description OBJECTIVES: To determine the in vitro susceptibility of Enterobacterales (n = 5457) and Pseudomonas aeruginosa (n = 1949) isolated from hospitalized patients in Africa (three countries) and the Middle East (five countries) in 2018–20 to a panel of 11 antimicrobials and to identify β-lactamase/carbapenemase genes in isolates with meropenem-non-susceptible and/or ceftazidime/avibactam-resistant phenotypes. METHODS: CLSI broth microdilution testing generated MICs that were interpreted using CLSI (2021) breakpoints. β-Lactamase/carbapenemase genes were identified using multiplex PCR assays. RESULTS: Enterobacterales isolates were highly susceptible to amikacin (96.7%), ceftazidime/avibactam (96.6%) and tigecycline (96.0%), and slightly less susceptible to meropenem (94.3%). In total, 337 Enterobacterales isolates (6.2% of all Enterobacterales isolates) carried one or more carbapenemase genes: 188 isolates carried a serine carbapenemase (178 OXA, 10 KPC) and 167 isolates carried an MBL (18 isolates carried both an MBL and an OXA). NDM-1 was the most common MBL identified (64.1% of NDM enzymes; 59.9% of all MBLs). OXA-48 (47.8%) and OXA-181 (38.8%) were the most common OXAs detected. P. aeruginosa isolates were most susceptible to ceftazidime/avibactam (89.1%) and amikacin (88.9%). Only 73.1% of P. aeruginosa isolates were meropenem susceptible. The majority (68.1%) of P. aeruginosa isolates tested for carbapenemase/β-lactamase genes were negative. In total, 88 isolates (4.5% of all P. aeruginosa isolates) carried one or more carbapenemase genes: 81 isolates carried an MBL and 8 carried a GES carbapenemase (1 isolate carried genes for both). CONCLUSIONS: Carbapenemase detection was closely associated with meropenem-non-susceptible phenotypes for Enterobacterales (89.1%) but not for P. aeruginosa (24.2%). Wide geographic variation in carbapenemase type and frequency of detection was observed.
format Online
Article
Text
id pubmed-9204471
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-92044712022-06-21 Carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa causing infection in Africa and the Middle East: a surveillance study from the ATLAS programme (2018–20) Karlowsky, James A Bouchillon, Samuel K El Mahdy Kotb, Ramy Mohamed, Naglaa Stone, Gregory G Sahm, Daniel F JAC Antimicrob Resist Original Article OBJECTIVES: To determine the in vitro susceptibility of Enterobacterales (n = 5457) and Pseudomonas aeruginosa (n = 1949) isolated from hospitalized patients in Africa (three countries) and the Middle East (five countries) in 2018–20 to a panel of 11 antimicrobials and to identify β-lactamase/carbapenemase genes in isolates with meropenem-non-susceptible and/or ceftazidime/avibactam-resistant phenotypes. METHODS: CLSI broth microdilution testing generated MICs that were interpreted using CLSI (2021) breakpoints. β-Lactamase/carbapenemase genes were identified using multiplex PCR assays. RESULTS: Enterobacterales isolates were highly susceptible to amikacin (96.7%), ceftazidime/avibactam (96.6%) and tigecycline (96.0%), and slightly less susceptible to meropenem (94.3%). In total, 337 Enterobacterales isolates (6.2% of all Enterobacterales isolates) carried one or more carbapenemase genes: 188 isolates carried a serine carbapenemase (178 OXA, 10 KPC) and 167 isolates carried an MBL (18 isolates carried both an MBL and an OXA). NDM-1 was the most common MBL identified (64.1% of NDM enzymes; 59.9% of all MBLs). OXA-48 (47.8%) and OXA-181 (38.8%) were the most common OXAs detected. P. aeruginosa isolates were most susceptible to ceftazidime/avibactam (89.1%) and amikacin (88.9%). Only 73.1% of P. aeruginosa isolates were meropenem susceptible. The majority (68.1%) of P. aeruginosa isolates tested for carbapenemase/β-lactamase genes were negative. In total, 88 isolates (4.5% of all P. aeruginosa isolates) carried one or more carbapenemase genes: 81 isolates carried an MBL and 8 carried a GES carbapenemase (1 isolate carried genes for both). CONCLUSIONS: Carbapenemase detection was closely associated with meropenem-non-susceptible phenotypes for Enterobacterales (89.1%) but not for P. aeruginosa (24.2%). Wide geographic variation in carbapenemase type and frequency of detection was observed. Oxford University Press 2022-06-17 /pmc/articles/PMC9204471/ /pubmed/35733913 http://dx.doi.org/10.1093/jacamr/dlac060 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Karlowsky, James A
Bouchillon, Samuel K
El Mahdy Kotb, Ramy
Mohamed, Naglaa
Stone, Gregory G
Sahm, Daniel F
Carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa causing infection in Africa and the Middle East: a surveillance study from the ATLAS programme (2018–20)
title Carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa causing infection in Africa and the Middle East: a surveillance study from the ATLAS programme (2018–20)
title_full Carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa causing infection in Africa and the Middle East: a surveillance study from the ATLAS programme (2018–20)
title_fullStr Carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa causing infection in Africa and the Middle East: a surveillance study from the ATLAS programme (2018–20)
title_full_unstemmed Carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa causing infection in Africa and the Middle East: a surveillance study from the ATLAS programme (2018–20)
title_short Carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa causing infection in Africa and the Middle East: a surveillance study from the ATLAS programme (2018–20)
title_sort carbapenem-resistant enterobacterales and pseudomonas aeruginosa causing infection in africa and the middle east: a surveillance study from the atlas programme (2018–20)
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204471/
https://www.ncbi.nlm.nih.gov/pubmed/35733913
http://dx.doi.org/10.1093/jacamr/dlac060
work_keys_str_mv AT karlowskyjamesa carbapenemresistantenterobacteralesandpseudomonasaeruginosacausinginfectioninafricaandthemiddleeastasurveillancestudyfromtheatlasprogramme201820
AT bouchillonsamuelk carbapenemresistantenterobacteralesandpseudomonasaeruginosacausinginfectioninafricaandthemiddleeastasurveillancestudyfromtheatlasprogramme201820
AT elmahdykotbramy carbapenemresistantenterobacteralesandpseudomonasaeruginosacausinginfectioninafricaandthemiddleeastasurveillancestudyfromtheatlasprogramme201820
AT mohamednaglaa carbapenemresistantenterobacteralesandpseudomonasaeruginosacausinginfectioninafricaandthemiddleeastasurveillancestudyfromtheatlasprogramme201820
AT stonegregoryg carbapenemresistantenterobacteralesandpseudomonasaeruginosacausinginfectioninafricaandthemiddleeastasurveillancestudyfromtheatlasprogramme201820
AT sahmdanielf carbapenemresistantenterobacteralesandpseudomonasaeruginosacausinginfectioninafricaandthemiddleeastasurveillancestudyfromtheatlasprogramme201820